Krystexxa

NDC 75987-058 · Horizon Therapeutics USA, Inc.

Generic namepegloticase

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS

Active ingredient(s)PEGLOTICASE

Strength8 mg/50mL

Pharmacologic classUrate Oxidase [CS], Uric Acid-specific Enzyme [EPC]

Marketing categoryBLA

Packages

75987-058-01 — 1 VIAL in 1 CARTON (75987-058-01) / 50 mL in 1 VIAL

J2507 — Injection, pegloticase, 1 mg Medicare Part B payment limit (ASP + 6%): $3929.34

FDA lists these products with the same active ingredient.

75987-080 — pegloticase

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.